Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Abeona Therapeutics Inc (ABEO) vs Kimberly Clark Corp (KMB) Price & Performance

Abeona Therapeutics IncTrade
Kimberly Clark CorpTrade

Price performance (Past 24H)

Key statistics

Abeona Therapeutics Inc vs Kimberly Clark Corp — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Kimberly Clark Corp trades at $108.02 (market cap $36.11B). The key difference: Kimberly Clark Corp is far larger — about 85.7× Abeona Therapeutics Inc's market cap, and Kimberly Clark Corp pays a 4.72% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.

ABEOKMB
Market Cap
$421.19M$36.11B
Sector
HealthConsumer Staples
52-Week High
$7.45$134.81
52-Week Low
$4.17$93.05
Enterprise Value
$276.10M$41.67B
Dividend Yield
4.72%

Returns comparison

Trailing returns across standard periods

About Abeona Therapeutics Inc

Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.

Read more on ABEO

About Kimberly Clark Corp

With around half of sales from personal care and another third from tissue products, Kimberly-Clark sits as a leading manufacturer of tissue and hygiene realm. Its brand mix includes Huggies, Pull-Ups, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary products for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.

Read more on KMB